Key result
Carvedilol significantly reduced mean heart rate from 101.9 to 85.2 bpm and total daily heart beats by 10.7% in patients with chronic atrial fibrillation.
Why the study?
Does carvedilol reduce heart rate in hypertensive patients with persistent or permanent atrial fibrillation without heart failure?
Does carvedilol reduce heart rate in hypertensive patients with persistent or permanent atrial fibrillation without heart failure?
Carvedilol effectively reduces heart rate and total heart beats in patients with chronic atrial fibrillation without heart failure, supporting its use in rate-control strategies.
Answers are grounded in this paper and cite their sources.
May support rate control with carvedilol in chronic AF without HF; leaves open need for RCTs in hypertensive patients.
BACKGROUND: Currently, β-blockers are used most frequently for the purpose of heart rate (HR) control in patients with atrial fibrillation (AF) in worldwide. Carvedilol is one of common β-blockers and known to be effective for hypertension and heart failure. However, little can be found the information about the HR-lowering effect of carvedilol in patients with AF without heart failure. Therefore, we conducted this study to investigate the effect of carvedilol on HR in 3-minute electrocardiogram (ECG) and total heart beats (THBs) in 24-hour Holter ECG monitoring in patients with persistent or permanent AF. METHODS: A total of 13 hypertensive patients (73 ± 12 years, 7 males) with AF and HR 90 bpm or more were enrolled. All patients received carvedilol from 5 mg/day. The dose of drug was titrated every 4 weeks and raised to 10 or 20 mg/day if HR was 80 bpm or more. RESULTS: Mean HR was decreased from 101.9 ± 13.9 to 85.2 ± 15.2 bpm (P < 0.05) after treatment with carvedilol. THBs were also significantly decreased from 128 to 115 × 1,000/day (P < 0.001). Percent reduction in HR and THBs were 13.9% and 10.7%, respectively. The scores of Atrial Fibrillation Quality of Life Questionnaire (AFQLQ) did not change. Only one patient was required to discontinue carvedilol due to congestive heart failure. CONCLUSIONS: We observed that carvedilol certainly reduced HR in patients with chronic AF. We believe that the effect of carvedilol on the reduction in HR can contribute to the management of AF patients treated with rate-control strategy.
No takes yet. Share an insight, caveat, or question.
Eitaro Kodani (2013) studied Chronic Atrial Fibrillation (n=13). Carvedilol vs. Baseline was evaluated on Mean heart rate in 3-minute ECG (13.9% reduction, p=<0.05). Carvedilol significantly reduced mean heart rate from 101.9 to 85.2 bpm and total daily heart beats by 10.7% in patients with chronic atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: